APIX Biosciences

Wingene ·KBO/BCE: BE 0771.667.563

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
30-04-2025	30-11-2025	28-11-2025	2 d early	2025-00572899
30-04-2024	30-11-2024	29-11-2024	1 d early	2024-00607526
30-04-2023	30-11-2023	22-12-2023	22 d late	2023-00535781
30-04-2022	30-11-2022	30-11-2022	on the day	2022-20528253

Metric	This company	Sector median	Position in the sector
Solvency	18.3%	49.8%	better than 30% of 81 sector peers
Net result	€-621k	€17k	better than 10% of 80 sector peers
Equity	€1.08M	€102k	better than 85% of 81 sector peers
Gross operating margin	€-149k	€49k	better than 8% of 76 sector peers
Total assets	€5.89M	€250k	better than 90% of 81 sector peers

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€5.89M
Fixed assets	21/28	€5.13M
Formation expenses	20	€63k
Intangible fixed assets	21	€4.67M
Tangible fixed assets	22/27	€302k
Financial fixed assets	28	€161k
Current assets	29/58	€698k
Amounts receivable within one year	40/41	€263k
Investments	50/53	€0
Cash & bank	54/58	€430k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€5.89M
Equity	10/15	€1.08M
Contributions / capital	10/11	€1.91M
Accumulated profits (losses)	14	€-829k
Amounts payable	17/49	€4.82M
Amounts payable after one year	17	€4.50M
Amounts payable within one year	42/48	€294k
Trade debts payable within one year	44	€225k
Income statement
Gross operating margin	9900	€-149k
Operating result	9901	€-681k
Financial income	75	€13k
Financial charges	65	€13k
Result before taxes	9903	€-680k
Income taxes	67/77	€-60k
Net result for the period	9904	€-621k
Result to be appropriated	9905	€-621k

Summary

NACE primary	Speur- en ontwikkelingswerk op biotechnologisch gebied(72101)
Legal form	Public limited company(014)
Incorporation	23-07-2021
Status	Active
Postal code	8750

Parcel (capakey)	Region	Area	Buildings	Height / fl.
37018C0214/00S002	Flanders	2,274 m²	1 · 2,877 m²	-
37018D0409/00R000	Flanders	2,204 m²	1 · 140 m²	7.4 m · 2 fl.
37018D0016/00H002	Flanders	644 m²	1 · 362 m²	12.7 m · 2 fl.